in laboratory tests , they prompted inactive mouse and human stem cells to regenerate myelin , the protective insulation-like coating around nerve fibres that is destroyed by the disease . lead scientist professor paul tesar , from case western reserve school of medicine , said : ' we appreciate that some patients or their families feel they can not wait for the development of specific approved medications , but off-label use of the current forms of these drugs is more likely to increase other health concerns than alleviate multiple sclerosis symptoms . ' the response was similar to that seen in mouse cells , with miconazole exerting the most potent effect .